Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Archives of Dermatology|August 1, 1976
Intravenous desensitization to mechlorethamine in patients with psoriasisD M Pariser, R C Childers, P Kechijian, et al.The British Journal of Dermatology|November 17, 2006
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow upE H Tschen, D S Wong, D M Pariser, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 11, 2021
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label studyM G Lebwohl, L Stein Gold, K Papp, et al.The British Journal of Dermatology|May 7, 2009
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trialD Y M Leung, J M Hanifin, D M Pariser, et al.Journal of the American Academy of Dermatology|June 19, 1998
Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernailR C Savin, L Drake, D Babel, et al.Journal of Patient-Reported Outcomes|September 6, 2019
Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severityL M Nelson, D DiBenedetti, D M Pariser, et al.Journal of the American Academy of Dermatology|July 21, 2001
A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acneJ S Strauss, J J Leyden, A W Lucky, et al.Journal of the American Academy of Dermatology|June 19, 1998
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernailL Drake, D Babel, D M Stewart, et al.Journal of the American Academy of Dermatology|July 21, 2001
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoinJ S Strauss, J J Leyden, A W Lucky, et al.The British Journal of Dermatology|September 27, 2017
Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled studyG J Schmieder, Z D Draelos, D M Pariser, et al.Pageof 5